Spots Global Cancer Trial Database for ebv
Every month we try and update this database with for ebv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis | NCT03650231 | EBV | Serological gia... | 3 Years - 82 Years | Centre Hospitalier Universitaire, Amiens | |
| PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. | NCT03755440 | Gastric Cancer ... EBV | PD-1 antibody (... | 18 Years - | Sun Yat-sen University | |
| The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation | NCT02976558 | Hematological N... Graft-Versus-Ho... Depression Stem Cell Trans... Quality of Life Leukemia | Clown theatrica... Acupuncture Music Therapy T... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Bortezomib Plus Rituximab for EBV+ PTLD | NCT01058239 | Post-transplant... Solid Organ Tra... Stem Cell Trans... Epstein Barr Vi... | bortezomib rituximab | 18 Years - | Massachusetts General Hospital | |
| PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. | NCT03755440 | Gastric Cancer ... EBV | PD-1 antibody (... | 18 Years - | Sun Yat-sen University | |
| A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | NCT00834093 | Nasopharyngeal ... | Epstein-Barr Vi... | 18 Years - | Dana-Farber Cancer Institute | |
| Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) | NCT03682055 | Nasopharyngeal ... Nasopharyngeal ... | VK-2019 | 18 Years - | Cullinan Therapeutics Inc. | |
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial | NCT03699904 | COPD EBV | Valaciclovir Placebo capsule... | 18 Years - | Belfast Health and Social Care Trust | |
| EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug | NCT03656965 | Drug Use for Un... | Acyclovir 800 M... Radiotherapy an... | - | Kuwait Cancer Control Center | |
| Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial | NCT04507477 | Epstein-Barr Vi... Post-transplant... | Rituximab | 18 Years - | University Health Network, Toronto | |
| Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) | NCT03682055 | Nasopharyngeal ... Nasopharyngeal ... | VK-2019 | 18 Years - | Cullinan Therapeutics Inc. | |
| Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors | NCT05707910 | Malignant Tumor | EBV immunologic... | 18 Years - 70 Years | West China Hospital | |
| Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients | NCT01744587 | NPC | Epigallocatechi... Placebo | 20 Years - | National Health Research Institutes, Taiwan | |
| Epstein-Barr Detection in Oral Cancer | NCT01039272 | Oral Cancer | 40 Years - | UPECLIN HC FM Botucatu Unesp | ||
| Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) | NCT00711035 | Adenovirus Infe... EBV Infection | Trivirus Specif... | - | Baylor College of Medicine | |
| KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial | NCT06097793 | Nasopharyngeal ... | KSD-101 | 18 Years - 70 Years | Kousai Bio Co., Ltd. | |
| Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors | NCT05714748 | Malignant Tumor... | EBV mRNA vaccin... | 18 Years - 70 Years | West China Hospital | |
| Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis | NCT05604378 | Gastric Cancer EBV Infection MSI | Gastrectomy | - | Saint Vincent's Hospital, Korea | |
| Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection | NCT04645147 | EBV Epstein-Barr Vi... Infectious Mono... | EBV gp350-Ferri... Matrix-M1 | 18 Years - 29 Years | National Institutes of Health Clinical Center (CC) | |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | NCT01972035 | Transplantation... Epstein-Barr Vi... Cytomegalovirus... | Valacyclovir Valganciclovir | - | University of Minnesota | |
| EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients | NCT00963248 | Epstein-Barr Vi... | - | Klinik für Kinder- und Jugendmedizin | ||
| Study on Infectious Mononucleosis in Munich | NCT06002802 | Infectious Mono... Epstein-Barr Vi... | 0 Years - 39 Years | Technical University of Munich | ||
| Epstein-Barr Detection in Oral Cancer | NCT01039272 | Oral Cancer | 40 Years - | UPECLIN HC FM Botucatu Unesp | ||
| Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma | NCT01948180 | Lymphoma, Extra... EBV | baltaleucel-T | 18 Years - | Cell Medica Ltd | |
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial | NCT03699904 | COPD EBV | Valaciclovir Placebo capsule... | 18 Years - | Belfast Health and Social Care Trust | |
| Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma | NCT04055558 | Childhood Leuke... | - 30 Years | Rabin Medical Center | ||
| Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas | NCT02388490 | Relapsed or Ref... | brentuximab ved... | 18 Years - | Seoul National University Hospital | |
| Family Study of Head and Neck Cancers in Taiwan | NCT00342147 | Nasopharyngeal ... Herpesvirus 4, ... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas | NCT02763254 | Hodgkin Lymphom... Lymphoma, Large... Post-transplant... | baltaleucel-T | 12 Years - | Cell Medica Ltd | |
| EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) | NCT00078546 | Nasopharyngeal ... EBV Infections | EBV specific CT... Anti CD45 monoc... | - | Baylor College of Medicine | |
| Genetic Studies of Chronic Active Epstein-Barr Disease | NCT00032513 | Chronic Active ... | 1 Year - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies | NCT04925544 | Nasopharyngeal ... Epstein-Barr Vi... | VK-2019 | 18 Years - | Stanford University | |
| Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation | NCT02878278 | Lymphoma, Extra... EBV | Chidamide BIW Chidamide QD | 18 Years - 75 Years | Sun Yat-sen University | |
| KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial | NCT05635591 | EBV-associated ... | Autologous mono... | 18 Years - 70 Years | Tongji Hospital | |
| Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma | NCT00226304 | HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial | NCT03699904 | COPD EBV | Valaciclovir Placebo capsule... | 18 Years - | Belfast Health and Social Care Trust | |
| EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) | NCT00078546 | Nasopharyngeal ... EBV Infections | EBV specific CT... Anti CD45 monoc... | - | Baylor College of Medicine | |
| The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation | NCT02976558 | Hematological N... Graft-Versus-Ho... Depression Stem Cell Trans... Quality of Life Leukemia | Clown theatrica... Acupuncture Music Therapy T... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | NCT01972035 | Transplantation... Epstein-Barr Vi... Cytomegalovirus... | Valacyclovir Valganciclovir | - | University of Minnesota | |
| Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma | NCT01449942 | Nasopharyngeal ... | DNAzyme targeti... Saline | - | Xiangya Hospital of Central South University | |
| Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma | NCT00226304 | HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections | NCT02231853 | Chronic Lymphoc... CML (Chronic My... MDS (Myelodyspl... Acute Lymphobla... AML (Acute Myel... | MVST MVSTr | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial | NCT03699904 | COPD EBV | Valaciclovir Placebo capsule... | 18 Years - | Belfast Health and Social Care Trust | |
| KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial | NCT06370026 | Nasopharyngeal ... | KSD-101 | 18 Years - 70 Years | Sun Yat-sen University | |
| Genetic Studies of Chronic Active Epstein-Barr Disease | NCT00032513 | Chronic Active ... | 1 Year - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH) | NCT01945619 | EBV Infection CMV Infection Adenoviral Infe... | Trivirus-Specif... | - | Baylor College of Medicine | |
| Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors | NCT05714748 | Malignant Tumor... | EBV mRNA vaccin... | 18 Years - 70 Years | West China Hospital | |
| PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | NCT03044743 | Stage IV Gastri... Stage IV Nasoph... T-Cell Lymphoma... Stage IV Adult ... Stage IV Diffus... | Fludarabine Cyclophosphamid... Interleukin-2 | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies | NCT04925544 | Nasopharyngeal ... Epstein-Barr Vi... | VK-2019 | 18 Years - | Stanford University | |
| Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) | NCT00711035 | Adenovirus Infe... EBV Infection | Trivirus Specif... | - | Baylor College of Medicine | |
| Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) | NCT00478465 | Chronic Fatigue... | valganciclovir | 18 Years - | Stanford University | |
| Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma | NCT01948180 | Lymphoma, Extra... EBV | baltaleucel-T | 18 Years - | Cell Medica Ltd | |
| EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients | NCT00963248 | Epstein-Barr Vi... | - | Klinik für Kinder- und Jugendmedizin | ||
| Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma | NCT00226304 | HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma | NCT04055558 | Childhood Leuke... | - 30 Years | Rabin Medical Center | ||
| Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly | NCT01671813 | Lymphoma | brentuximab ved... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
